Gainers & Losers
Mon Nov 25 2024 10:23:34- Larsen & Toubro share price
- ₹3,753.254.13%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
- Wipro share price
- ₹582.751.99%
- ICICI Bank share price
- ₹1,301.501.82%
Active Stocks
Mon Nov 25 2024 10:27:51- Adani Power share price
- ₹446.85-3.02%
- Power Grid Corporation Of ...
- ₹342.851.74%
- Tata Steel share price
- ₹143.600.56%
- State Bank Of India share price
- ₹844.753.52%
- HDFC Bank share price
- ₹1,784.602.21%
Aarti Drugs Profit & Loss Annual
Trade453.70 +4.70 (1.05%)Updated : 25 Nov 2024
| Fiscal Period | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
| Revenue | 2,528.58 | 2,716.05 | 2,488.65 | 2,154.78 |
| Total Revenue | 2,528.58 | 2,716.05 | 2,488.65 | 2,154.78 |
| Costof Revenue Total | 1,677.72 | 2,201.43 | 1,967.42 | 1,539.31 |
| Gross Profit | 850.86 | 514.62 | 521.23 | 615.47 |
| Selling/ General/ Admin Expenses Total | 102.34 | 191.38 | 177.01 | 165.73 |
| Depreciation/ Amortization | 51.45 | 50.32 | 50.05 | 49.88 |
| Other Operating Expenses Total | 432.06 | 9.14 | 7.26 | 4.70 |
| Total Operating Expense | 2,263.57 | 2,456.93 | 2,206.10 | 1,767.33 |
| Operating Income | 265.01 | 259.13 | 282.55 | 387.45 |
| Interest Inc( Exp) Net- Non- Op Total | -335.20 | -315.36 | -171.49 | -176.61 |
| Other Net | 4.04 | -3.41 | 4.56 | -4.04 |
| Net Income Before Taxes | 235.53 | 224.18 | 269.96 | 369.01 |
| Provisionfor Income Taxes | 63.93 | 57.82 | 64.96 | 88.62 |
| Net Income After Taxes | 171.60 | 166.36 | 205.00 | 280.40 |
| Minority Interest | -0.17 | -0.05 | 0.04 | 0.01 |
| Net Income Before Extra Items | 171.43 | 166.31 | 205.04 | 280.41 |
| Net Income | 171.43 | 166.31 | 205.04 | 280.41 |
| Total Adjustmentsto Net Income | -0.08 | - | - | - |
| Income Availableto Com Excl Extra Ord | 171.42 | 166.31 | 205.04 | 280.41 |
| Income Availableto Com Incl Extra Ord | 171.42 | 166.31 | 205.04 | 280.41 |
| Diluted Net Income | 171.42 | 166.31 | 205.04 | 280.41 |
| Diluted Weighted Average Shares | 9.24 | 9.26 | 9.26 | 9.32 |
| Diluted EPS Excluding Extra Ord Items | 18.56 | 17.96 | 22.14 | 30.09 |
| Diluted Normalized EPS | 18.56 | 17.96 | 22.14 | 30.07 |
| Research Development | - | 46.55 | 43.58 | 46.64 |
| DPS- Common Stock Primary Issue | - | 1.00 | 1.00 | 2.50 |
| Unusual Expense( Income) | - | - | 0.00 | 3.04 |
| Gain( Loss)on Saleof Assets | - | - | 0.00 | 32.67 |
*All figures in crores except per share values
Aarti Drugs Quick Links
Aarti Drugs Dividend Aarti Drugs Bonus Aarti Drugs News Aarti Drugs AGM Aarti Drugs Rights Aarti Drugs Splits Aarti Drugs Board Meetings Aarti Drugs Key Metrics Aarti Drugs Shareholdings Aarti Drugs Balance Sheet Aarti Drugs Cashflow Aarti Drugs Q1 Results Aarti Drugs Q2 Results Aarti Drugs Q3 Results Aarti Drugs Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
3,753.25+148.70(4.13%)
844.75+28.70(3.52%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)